Clinical Outcomes in Patients With Metastatic Lung Cancer Treated With PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 28973343.
- Also identified by DOI 10.1001/jamaoncol.2017.3808 and PMC identifier 5838581.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study evaluates the clinical outcomes in patients with metastatic lung cancer treated with PD-1/PD-L1 inhibitors and thoracic radiotherapy.
Medical subject headings
- Antineoplastic Agents, Immunological
- B7-H1 Antigen
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Programmed Cell Death 1 Receptor